Sign in

CIK 0001840229 · <br>Emerging growth company

MiNK Therapeutics, Inc.

Sign in to watch
Ticker
INKT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
212-994-8250
Business address
149 FIFTH AVENUE, SUITE 500, NEW YORK, NY, 10010
Former names
AgenTus Therapeutics, Inc., AgenTus Therapeutics, Inc.
  1. 3 Insider Initial Statement of Ownership
  2. 3 Insider Initial Statement of Ownership
  3. 3 Insider Initial Statement of Ownership
  4. 3 Insider Initial Statement of Ownership
  5. 3 Insider Initial Statement of Ownership
  6. 3 Insider Initial Statement of Ownership
  7. 3 Insider Initial Statement of Ownership
  8. 8-K Event Shareholder rights changed · Bylaws or fiscal year change
  9. 424B4 Offering Prospectus
  10. FWP Offering Free Writing Prospectus
  11. EFFECT Other Notice of Effectiveness
  12. CERT Other Certification
  13. 8-A12B Other Registration of Securities
  14. CORRESP Other Correspondence Between Filers and SEC Staff
  15. CORRESP Other Correspondence Between Filers and SEC Staff
  16. S-1/A Offering Registration Statement
  17. CORRESP Other Correspondence Between Filers and SEC Staff
  18. S-1 Offering Registration Statement
  19. CORRESP Other Correspondence Between Filers and SEC Staff
  20. UPLOAD Other SEC-generated Letter

Page 13 of 14 · 267 filings